AmblyoPlay, the award-winning vision therapy solution for children with lazy eye, has been recognized by General Electrics Healthcare division (GE HealthCare) and European Institute of Innovation & Technology – Health (EIT Health). Smart Optometry – the team behind AmblyoPlay – has been invited to take part in an intensive incubation program Health Ventures Lab, which is taking place in Budapest, Hungary.
Health Venture Lab is much more than just an incubation or acceleration program for startups. It’s a community that provides companies and solutions with greatest potential with tools, resources and expertise for faster and more profound disruption of healthcare. Inclusion in this exclusive program gives a big nod to the work done so far by the team behind AmblyoPlay and their commitment to always pushing the limits of technology in pursuit of providing best, most reliable and most efficient solutions for eye care.
EIT Health is a network of best-in-class health innovators backed by the EU. Their aim is to deliver solutions that enable European citizens to live longer, healthier lives by promoting innovation, so that innovation can happen at the intersection of research, education and business – for the benefit of citizens. GE Healthcare is a leading global medical technology and life sciences company that provides a broad portfolio of products, solutions and services used in the diagnosis, treatment and monitoring of patients. One of their goals is to help improve outcomes for healthcare provides and for therapy innovators around the world.
“Being among the chosen companies by EIT Health and GE Healthcare is an amazing honor and opportunity to take our company and our portfolio of solutions even further. Our aim as a company is to provide reliable and effective digital solutions that improve the lives of young patients with lazy eye. Their trust in our solution speaks volumes!” said Zan Menart, CEO of Smart Optometry.
GE Healthcare and EIT Health join other prominent players, who already backed Smart Optometry and their products in the past, among others Bayer (through EyeFocus program) as well as two corporate VCs that invested in the young and innovative health startup, which was awarded as the most innovative company of 2018 by Slovenian Chamber of Commerce.